Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

8.15
Delayed Data
As of Mar 27
 +0.168 / +2.10%
Today’s Change
4.71
Today|||52-Week Range
9.24
+8.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.00100.0K10.0K1.7M
 
 
 
 
Cost of Goods Sold0.000.000.001.1M
 
 
Depreciation And Amortization338.002.9K5.7K--
 
 
 
 
 
Operating ExpensesGross Income-338.0097.1K4.3K567.4K
 
 
 
 
 
General Expenses938.9K4.3M7.7M10.7M
 
 
 
 
 
Other Operating Expenses0.001.6K0.00--
 
 
Research And Development111.6K1.3M1.6M236.7K
 
 
 
 
 
Total Operating Expenses939.2K4.3M7.7M11.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-939.2K-4.2M-7.7M-10.1M
 
 
 
 
 
Extraordinary Credit60.3K0.000.00--
 
 
Extraordinary Charge0.00-1.2M0.00--
 
 
Interest Expense On Debt75.0K24.7K0.00--
 
 
 
Other Expenses0.000.000.0028.6K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-953.9K-5.4M-7.6M--
 
 
 
 
Preferred Dividend-100.0K-200.0K0.00--
 
 
 
Net Income-953.9K-5.4M-7.6M--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS397.8K4.5M8.7M--
 
 
 
 
Shares To Calculate EPS Diluted397.8K4.5M8.7M--
 
 
 
 
 
Earnings Per ShareEPS-$2.80-$1.24-$0.88-$1.11
 
 
 
 
 
EPS Diluted-$2.80-$1.24-$0.88-$1.11
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account